influenza

17 · 20 / page

Ask MedXY AI

Latest news

Tag

Infectious Diseasesalveolar macrophagesinfluenza

Decoding the Pulmonary Immune Landscape in Influenza: Insights from a Large-Scale Single-Cell Atlas

By MedXY|Jul 17, 2026

A comprehensive single-cell atlas of lung immune cells reveals distinct immune responses in mild versus severe influenza, highlighting neutrophil dysfunction and lymphocyte impairment as key drivers of pathology.

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks: Evidence Synthesis and Clinical Implications

Clinical Updatesantiviral chemoprophylaxis

influenza

Latest news

Decoding the Pulmonary Immune Landscape in Influenza: Insights from a Large-Scale Single-Cell Atlas

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks: Evidence Synthesis and Clinical Implications

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks

Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut Hospitalizations

Optimizing Influenza Protection in Older Adults with Diabetes: Insights from the DANFLU-2 Trial

RSV Frequently Precedes Influenza Peaks: Mapping the Temporal Sequence of the Post-Pandemic Triple-Threat in the United States

Comprehensive Review of Digital Nudges to Enhance Influenza Vaccination Uptake in Chronic and Cardiovascular Disease Patients

High-Dose Influenza Vaccination Reduces Hospitalizations and Cardiovascular Events in Older Adults: Insights from the FLUNITY-HD Pooled Analysis

Beyond the Common Cold: Deciphering the Surge of Influenza Subclade K Across Europe

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial

IDSA 2025 Update: Stronger Flu and RSV Vaccine Recommendations for Immunocompromised People — What Clinicians Need to Know

A Novel H3N2 Variant on the Rise: What Clinicians and Public Health Systems Need to Know for 2025–26

How Well Do Flu Vaccines Protect Kids? A 20-Year Look at Live and Inactivated Influenza Vaccines

Evolving Patterns of Clinical Testing for SARS-CoV-2, Influenza, and RSV in Hospitalized Youths (2016–2024): Insights and Implications

Declining Antiviral Prescribing for High-Risk Children with Influenza in US Pediatric Emergency Departments During the COVID-19 Era

High-Dose and Adjuvanted Flu Vaccines Offer Equivalent Protection for Older US Adults

Influenza-Associated Acute Necrotizing Encephalopathy in US Children